Search Videos and More
Cancer center director joins panel discussion at Nixon National Cancer Conference on the complexity of cancer care today
UCI Health was a major sponsor of the 2025 Nixon National Cancer Conference (NNCC) held at the Richard Nixon Presidential Library and Museum in Yorba Linda.Richard Van Etten, MD, PhD shares a year of advancements in cancer care
UCI Medical Center is committed to excellence and research in cancer care.UCI Health physician recognized by the Society of Surgical Oncology
Oliver Eng, MD has received the prestigious Lisa Kurtz Luciano Appendix Cancer and Pseudomyxoma Peritonei Clinical Investigator Award.Young dancer triumphs over rare pancreatic tumor
A CT scan at Children's Hospital of Orange revealed a mass on her pancreas, leading to a referral to UCI Health Chao Digestive Health Institute.Internationally regarded leukemia pioneer Dr. Susan O'Brien honored for advancing research, treatment
Internationally renowned UCI Health hematologist-oncologist Dr. Susan O’Brien has been honored with the Excellence in Scientific Service Award by the Leukemia & Lymphoma Society for her vast contributions to the field.Thoracic Surgeon, Ali Mahtabifard, MD, Treats Musician Who is Now Cancer-Free
"Dr. Mahtabifard is my hero," said Green Day's Jason Freese after beating lung cancer.Targeted therapy a game changer for metastatic breast cancer
Mohammadbagher Ziari, MD, used olaparib to successfully treat a patient's metastatic breast cancer which is now in remission.Advanced care enabled by seamless collaboration
Cutting-edge technology integrated with a team-based approach, allows UCI Health to deliver precise treatment quickly and effectively.Stereotactic radiosurgery (SRS) at UCI Health
These noninvasive treatments target even the smallest, hardest-to-reach tumors with sub-millimeter precision.Next-generation testing in patients with non-small cell lung cancer
Tumor sequencing at the time of progression, whether tissue or liquid biopsy, is important to identify the mechanism of resistance.Survey of actionable driver mutations KRAS and EGFR in non–small cell lung cancer
Molecularly targeted therapies have advanced treatment for certain cancers, such as lung cancer with specific EGFR or KRAS mutations. However, oftentimes the tumor becomes eventually treatment resistant.Head and neck oncologist discusses advanced treatment paradigms presented at ASCO 2024
Hear why attending this meeting improves her ability to care for patients with metastatic disease.